Latest News

Latest News

News from the World Hepatitis Alliance

Viral Hepatitis and the Sustainable Development Goals: driving action towards elimination

24 Feb 2016 Tara Farrell

Today, leading medical professionals, policymakers, civil society and patients gathered at a policy symposium organised by the Coalition to Eradicate...

World Hepatitis Day 2016 theme announced

23 Feb 2016 Bridie Taylor

With the first ever WHO Global Elimination Strategy on Viral Hepatitis set for its likely adoption at the World Health Assembly in May, 2016 will be...

Meeting an unmet need: the road from Alice Springs to Brazil

23 Feb 2016 Tara Farrell

Viral hepatitis is a major, devastating and under-recognised health issue within Indigenous communities worldwide, affecting thousands of people each...

Hepatitis C Elimination Manifesto to be launched in Brussels tomorrow

16 Feb 2016 Bridie Taylor

Tomorrow, George Kalamitsis, WHA Executive Board Member for the European Region and Charles Gore, WHA President, will join over 100 European and...

World Hepatitis Alliance seeks highly organised individual for Officer Manager vacancy

8 Feb 2016 Bridie Taylor

Make a positive change this year and join us in our fight to eliminate hepatitis. We are looking for experienced Office Manager to join our dynamic...

80% of liver cancer deaths can be prevented, saving hundreds of thousands of lives each year globally

4 Feb 2016 Tara Farrell

On World Cancer Day, the World Hepatitis Alliance is calling for the establishment of comprehensive hepatitis strategies to help prevent the 800,000...

World Hepatitis Alliance seeks motivated Project Assistant to help organise the World Hepatitis Summit

3 Feb 2016 Bridie Taylor

Make a positive change this year and join us in our fight to eliminate hepatitis. We are looking for an organised and motivated Project Assistant to...

A step towards the elimination of viral hepatitis

28 Jan 2016 Tara Farrell

Today, Member States and civil society groups convened at the World Health Organization (WHO) Executive Board (EB) meeting in Geneva to discuss the...

New addition to the WHA team

28 Jan 2016 Bridie Taylor

Preparations for the second World Hepatitis Summit (WHS2017), taking place in Brazil early 2017, are now underway and the World Hepatitis Alliance...

WHA presents Tools For Change webinar series to enhance patient advocacy

27 Jan 2016 Bridie Taylor

Patient group advocacy has the power to effect real lasting change and improve the lives of millions living with viral hepatitis. We believe that...

Welcoming five new members to the World Hepatitis Alliance

26 Jan 2016 Bridie Taylor

This month, we welcome five new organisations to the World Hepatitis Alliance. Our alliance is now made up of 230 organisations in 81 countries in...

Hepatitis Testing Innovation Contest now open for submissions!

19 Jan 2016 Tara Farrell

Do you have a new and exciting idea on how to deliver hepatitis B and C testing? Be in with a chance to contribute to the 2016 WHO Hepatitis Testing...

World Hepatitis Day 2015 Summary Report released

19 Jan 2016 Bridie Taylor

On 28 July, World Hepatitis Day (WHD) brings the world together to raise awareness of the global burden of viral hepatitis and to influence real...

Public health experts, patients and policymakers convene at inaugural African Viral Hepatitis Summit to discuss the need for comprehensive national plans

19 Jan 2016 Tara Farrell

Today, more than 100 leading African and international public health experts, patient representatives, policymakers and physicians have gathered in...

Patient Solidarity Day: Uniting to declare healthcare a human right

3 Dec 2015 Bridie Taylor

On 5th December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that healthcare is a human right. Co-ordinated by...

Welcoming four new members

2 Dec 2015 Bridie Taylor

The World Hepatitis Alliance continues to grow as we welcome four new member organisations. Our membership is now made up of over 225 groups in 81...

HIV patients with viral hepatitis are three times more likely to have liver disease, liver failure and liver-related deaths

1 Dec 2015 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2015 -...

Innovative patent agreement shows success of patient advocacy

23 Nov 2015 Bridie Taylor

The World Hepatitis Alliance congratulates the Medicines Patent Pool (MPP) and Bristol – Myers Squibb (BMS) for recognising the global hepatitis...

Medicines Patent Pool expands its mandate to hepatitis C treatment

6 Nov 2015 Bridie Taylor

The World Hepatitis Alliance welcomes the recent announcement from the Medicines Patent Pool (MPP) that they will be expanding their mandate to...

The global hepatitis community unites to demand access to life-saving hepatitis treatment

2 Nov 2015 Bridie Taylor

London, 2 November 2015: Today the World Hepatitis Alliance launches an open letter calling for immediate action to vastly improve access to life-...

Pages

News from infohep

Diabetes raises the risk of liver damage in people with HIV

21 Sep 2020 Keith Alcorn
Almost half of people with HIV with unexplained liver enzyme elevations or other abnormal liver markers had non-alcoholic steatohepatitis (NASH) and...

Models can help predict liver cancer in people cured of hepatitis C

17 Sep 2020 Liz Highleyman
Three new methods using readily available clinical parameters can help predict who will develop hepatocellular carcinoma (HCC) after achieving...

International registries provide more information about COVID-19 and liver disease

17 Sep 2020 Liz Highleyman
People with advanced liver cirrhosis are more likely to develop severe COVID-19 complications and to die from it, but those who have received liver...

Aldafermin reduces liver fat in phase 2 study

14 Sep 2020 Keith Alcorn
Aldafermin significantly reduced liver fat content and liver damage in a phase 2 study of a 24-week treatment course, Dr Stephen Harrison, Visiting...

Fatty liver disease affects one in four in Europe, study estimates

7 Sep 2020 Keith Alcorn
Non-alcoholic fatty liver disease affects one in four people in the general population in Europe and just over one in twenty people have advanced...

Stopping antivirals may offer a chance for a hepatitis B cure

6 Sep 2020 Liz Highleyman
Discontinuation of long-term nucleoside/nucleotide antiviral treatment for hepatitis B can allow some people to achieve a cure, according to a pair...

Immunotherapy combinations show promise for advanced liver cancer

2 Sep 2020 Liz Highleyman
Three checkpoint inhibitor immunotherapy regimens show promise for people with hepatocellular carcinoma (HCC), the most common type of liver cancer,...

Gilead immune modulator has modest effect on hepatitis B surface antigen

1 Sep 2020 Keith Alcorn
Selgantolimod, a toll-like receptor agonist designed to enhance immune responses to hepatitis B virus, showed only modest effects on hepatitis B...

Bulevirtide shows promise as maintenance therapy for hepatitis D

30 Aug 2020 Liz Highleyman
High-dose bulevirtide (Hepcludex) combined with pegylated interferon alfa-2a (Pegasys) or tenofovir disoproxil fumarate (TDF; Viread) led to...

JNJ-3989 achieves sustained reductions in hepatitis B surface antigen

29 Aug 2020 Keith Alcorn
Johnson & Johnson’s short interfering RNA treatment for hepatitis B resulted in sustained reductions in hepatitis B surface antigen when...